Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study
Background Current guidelines recommend either low-molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs) as first-line treatment in cancer-associated venous thromboembolism (VTE).
Main Authors: | Fleur H.J. Kaptein, Noori A.M. Guman, Susan B. Lohle, Frederikus A. Klok, Albert T.A. Mairuhu, Pieter W. Kamphuisen, Nick Van Es, Menno V. Huisman |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2024-01-01
|
Series: | TH Open |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2214-8101 |
Similar Items
-
Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark
by: Frederikus A. Klok, et al.
Published: (2020-10-01) -
Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey
by: Hope P. Wilson, et al.
Published: (2022-03-01) -
Assessment of adherence level of patients on anticoagulant therapy in a tertiary healthcare facility in Uyo, Nigeria
by: Ekwere TA, et al.
Published: (2021-01-01) -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
by: Marcello Di Nisio, et al.
Published: (2024-05-01) -
Diagnostic Management of Acute Pulmonary Embolism in COVID-19 and Other Special Patient Populations
by: Emily S. L. Martens, et al.
Published: (2022-05-01)